about
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its pro...
Read More
1.91
0.16
(9.14%)
7.3M
XNAS Volume
XNAS 05 Sep, 2025 4:18 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Equillium Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..